Marjorie M Walker1,2, Nicholas J Talley3,4. 1. Faculty of Health & Medicine, University of Newcastle, Callaghan, 2305, NSW, Australia. 2. Australian Gastrointestinal Research Alliance (AGIRA), Callaghan, 2305, NSW, Australia. 3. Faculty of Health & Medicine, University of Newcastle, Callaghan, 2305, NSW, Australia. Nicholas.Talley@newcastle.edu.au. 4. Australian Gastrointestinal Research Alliance (AGIRA), Callaghan, 2305, NSW, Australia. Nicholas.Talley@newcastle.edu.au.
Abstract
PURPOSE OF REVIEW: Functional dyspepsia is a common condition, and the condition is defined by symptoms using Rome IV criteria. This review addresses the issue of functional dyspepsia in elderly patients, epidemiology, investigation, and treatment. RECENT FINDINGS: Recent studies show that while the prevalence of dyspepsia declines in the elderly, it is still prevalant investigations to confirm the diagnosis (including mandatory upper gastrointestinal endoscopy) must exclude organic disease. These include ulcers (particularly associated with nonsteroidal antiinflammatory drugs), Helicobacter pylori pathologies, cancer, coeliac disease, and autoimmune gastritis. Recent research is unraveling pathophysiology beyond symptom-only definitions, focusing on the duodenum with innate immune disturbance (duodenal eosinophilia) and microbial disruption as possible cause. Management of functional dyspepsia includes making a secure diagnosis, treatment with first-line proton pump inhibitors (PPI), then tricyclic antidepressants, and careful choice of prokinetics. Herbal treatments (peppermint oil) and STW-5 have in this age group limited efficacy. Further studies are needed to define the prevalence of functional dyspepsia in the elderly and of prime importance, to exclude organic disease as a cause for symptoms of dyspepsia.
PURPOSE OF REVIEW: Functional dyspepsia is a common condition, and the condition is defined by symptoms using Rome IV criteria. This review addresses the issue of functional dyspepsia in elderly patients, epidemiology, investigation, and treatment. RECENT FINDINGS: Recent studies show that while the prevalence of dyspepsia declines in the elderly, it is still prevalant investigations to confirm the diagnosis (including mandatory upper gastrointestinal endoscopy) must exclude organic disease. These include ulcers (particularly associated with nonsteroidal antiinflammatory drugs), Helicobacter pylori pathologies, cancer, coeliac disease, and autoimmune gastritis. Recent research is unraveling pathophysiology beyond symptom-only definitions, focusing on the duodenum with innate immune disturbance (duodenal eosinophilia) and microbial disruption as possible cause. Management of functional dyspepsia includes making a secure diagnosis, treatment with first-line proton pump inhibitors (PPI), then tricyclic antidepressants, and careful choice of prokinetics. Herbal treatments (peppermint oil) and STW-5 have in this age group limited efficacy. Further studies are needed to define the prevalence of functional dyspepsia in the elderly and of prime importance, to exclude organic disease as a cause for symptoms of dyspepsia.
Authors: F K Chan; S C Chung; B Y Suen; Y T Lee; W K Leung; V K Leung; J C Wu; J Y Lau; Y Hui; M S Lai; H L Chan; J J Sung Journal: N Engl J Med Date: 2001-03-29 Impact factor: 91.245
Authors: Steven O Ikenberry; M Edwyn Harrison; David Lichtenstein; Jason A Dominitz; Michelle A Anderson; Sanjay B Jagannath; Subhas Banerjee; Brooks D Cash; Robert D Fanelli; Seng-Ian Gan; Bo Shen; Trina Van Guilder; Kenneth K Lee; Todd H Baron Journal: Gastrointest Endosc Date: 2007-10-29 Impact factor: 9.427
Authors: Paul Moayyedi; John W Eikelboom; Jackie Bosch; Stuart J Connolly; Leanne Dyal; Olga Shestakovska; Darryl Leong; Sonia S Anand; Stefan Störk; Kelley R H Branch; Deepak L Bhatt; Peter B Verhamme; Martin O'Donnell; Aldo P Maggioni; Eva M Lonn; Leopoldo S Piegas; Georg Ertl; Matyas Keltai; Nancy Cook Bruns; Eva Muehlhofer; Gilles R Dagenais; Jae-Hyung Kim; Masatsugu Hori; P Gabriel Steg; Robert G Hart; Rafael Diaz; Marco Alings; Petr Widimsky; Alvaro Avezum; Jeffrey Probstfield; Jun Zhu; Yan Liang; Patricio Lopez-Jaramillo; Ajay K Kakkar; Alexander N Parkhomenko; Lars Ryden; Nana Pogosova; Antonio L Dans; Fernando Lanas; Patrick J Commerford; Christian Torp-Pedersen; Tomek J Guzik; Dragos Vinereanu; Andrew M Tonkin; Basil S Lewis; Camilo Felix; Khalid Yusoff; Kaj P Metsarinne; Keith A A Fox; Salim Yusuf Journal: Gastroenterology Date: 2019-05-29 Impact factor: 22.682
Authors: William F Anderson; Charles S Rabkin; Natalie Turner; Joseph F Fraumeni; Philip S Rosenberg; M Constanza Camargo Journal: J Natl Cancer Inst Date: 2018-06-01 Impact factor: 13.506
Authors: Tobias Liebregts; Birgit Adam; Christoph Bredack; Montri Gururatsakul; Katherine R Pilkington; Stuart M Brierley; L Ashley Blackshaw; Guido Gerken; Nicholas J Talley; Gerald Holtmann Journal: Am J Gastroenterol Date: 2011-01-18 Impact factor: 10.864
Authors: Noémi Zádori; Dávid Németh; Levente Frim; Nóra Vörhendi; Lajos Szakó; Szilárd Váncsa; Péter Hegyi; József Czimmer Journal: Int J Gen Med Date: 2022-10-12